Iridium Catalyst for Ketone Reduction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing optically active alcohols are limited by the high cost of catalysts and reduced enantiomeric excess when using ketones with a carbonyl group bound to an aromatic ring via a methylene group, making them non-versatile for industrial applications.

Innovation Solution

An iridium(III) complex with a chiral prolinamide compound is used as a catalyst for asymmetric reduction of ketones, allowing for high enantiomeric excess and broad structural compatibility of starting material ketones, including those with a carbonyl group bound to an aromatic ring via a methylene group.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If a chiral ruthenium complex with Tsdpen ligand is used as catalyst, then high enantiomeric excess is achieved for ketones with carbonyl group bound directly to aromatic ring, but the catalyst cost becomes prohibitively expensive for industrial application

Engineering Contradiction:
Improveenantiomeric excessVSAvoidcatalyst cost
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The patent replaces the expensive Tsdpen ligand with a cheaper alternative ligand system that can be used in catalytic amounts. The new catalyst system uses readily available ligands such as phosphines or nitrogen-containing ligands combined with metal complexes, eliminating the need for costly chiral diamine ligands while maintaining catalytic activity and enantioselectivity.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The patent modifies the catalyst composition by changing the ligand type and metal center parameters. Instead of using rhodium or ruthenium with Tsdpen, the invention employs alternative metal complexes with different ligand systems, optimizing the balance between cost, activity, and selectivity for industrial applications.

Inventive Principle:
Principle #35Parameter changes

2Manufacturing precision

If a chiral ruthenium complex with Tsdpen ligand is used as catalyst, then good enantiomeric excess is achieved for aromatic ketones, but the method fails to maintain high enantiomeric excess for ketones with carbonyl group bound to aromatic ring via methylene group

Engineering Contradiction:
Improveenantiomeric excessVSAvoidsubstrate scope
Core Design Contradiction:
Manufacturing precisionVSAdaptability or versatility

Solution Approach 1:

The patent develops a catalyst system with broad substrate scope that can effectively reduce various types of ketones including aromatic ketones, aliphatic ketones, and ketones with methylene groups between carbonyl and aromatic ring. The universal catalyst design incorporates flexible ligand systems that can adapt to different substrate structures while maintaining high enantioselectivity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The invention optimizes catalyst parameters including metal center selection, ligand type, and stoichiometry to achieve consistent high enantiomeric excess across diverse ketone substrates. The modified catalyst system adjusts its coordination geometry and electronic properties to accommodate different substrate classes.

Inventive Principle:
Principle #35Parameter changes

3Manufacturing precision

If conventional asymmetric reduction methods are used, then high enantiomeric excess is achieved for specific ketone structures, but the method requires specialized equipment such as high-pressure hydrogen gas systems

Engineering Contradiction:
Improveenantiomeric excessVSAvoidequipment requirements
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent replaces high-pressure hydrogen gas delivery systems with transfer hydrogenation using liquid or gaseous organic hydrogen donors. This substitution eliminates the need for specialized high-pressure equipment, safety systems for handling compressed hydrogen, and complex reactor designs, while maintaining catalytic asymmetric reduction capability.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The invention changes the hydrogen source from molecular hydrogen under pressure to organic hydrogen donors that can be handled under mild conditions. The reaction parameters including temperature, pressure, and solvent systems are optimized for transfer hydrogenation, simplifying the overall process equipment requirements.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method enables the production of optically active alcohols in high optical and chemical purities from various ketones, using an inexpensive catalyst, thus overcoming the limitations of existing technologies and providing industrial versatility.

Implementation Method 1

asymmetric reduction of ketones using this catalyst

Methodology Applied
Scientific EffectCatalysis: Catalysis

Implementation Method 2

asymmetric reduction of ketones, and found the surprising results that, regardless of the structure of starting material ketones, optically active alcohols are generally obtainable in high enantiomeric excess

Methodology Applied
Scientific EffectAsymmetric reduction: Reduction

Data Source

PatentEP2772476B1Method for producing optically active alcohol
Publication Date: 2017.01.11 HAMARI CHEM LTD
  • EP2772476B1 patent drawing
  • EP2772476B1 patent drawing
  • EP2772476B1 patent drawing

AI summary

Provided is an industrially advantageous method for producing optically active alcohols in high yields from ketones of various structures by using an inexpensive chiral catalyst. The method of the present invention for producing optically active alcohols comprises reducing a ketone in the presence of an iridium(III) complex having a chiral prolinamide compound as a ligand. The ketone is preferably a compound represented by formula [I]: (wherein R1 and R2 are different from each other, and each represent an optionally substituted straight or branched alkyl group, an optionally substituted cycloalkyl group, an optionally substituted aryl group, an optionally substituted heteroaryl group, an optionally substituted aralkyl group, an optionally substituted heteroarylalkyl group, an optionally substituted alkenyl group or an optionally substituted alkynyl group, and R1 and R2 may be bound to each other at any appropriate position to form a ring, the ring optionally containing one or more atoms which may be the same or different and are selected from an oxygen atom, an optionally substituted nitrogen atom and a sulfur atom, and optionally being condensed with an aromatic or hetero-aromatic ring).